1393.00p-25.00 (-1.76 %)23 Nov 2020, 16:45
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Abcam PLC Fundamentals

Company NameAbcam PLCLast Updated2020-11-23
Shares in Issue226.552 mMarket Cap£3.16 bn
PE Ratio232.56Dividend per Share£0.12
Dividend Yield0.86Dividend Cover0.49
EPS£0.06EPS Growth (%)-0.73
PEG0DPS Growth (%)0
Debt Ratio0.2886Debt Equity Ratio0.2398
Asset Equity Ratio1.6144Cash Equity Ratio0.3727
Quick Ratio1.4624Current Ratio1.75
Price To Book Value0ROCE0

Abcam PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Abcam PLC Company Financials

Tangible Assets£164.70 m£37.10 m£25.10 m£22.30 m
Intangible Assets£347.20 m£227.60 m£220.50 m£189.10 m
Total Fixed Assets£532.60 m£274.90 m£254.90 m£218.20 m
Stocks£40.70 m£36.00 m£29.60 m£21.80 m
Cash & Equivalents£187.30 m£87.10 m£90.20 m£85.80 m
Other Assets0000
Total Assets£811.40 m£446.70 m£414.80 m£361.70 m
Creditors within 1 year£159.60 m£45.30 m£49.00 m£32.60 m
Creditors after 1 year£149.20 m£16.60 m£14.10 m£22.00 m
Other Liabilities0000
Total Liabilities£308.80 m£61.90 m£63.10 m£54.60 m
Net assets£502.60 m£384.80 m£351.70 m£307.10 m
Called up share capital£400,000.00£400,000.00£400,000.00£400,000.00
Share Premium£138.20 m£27.00 m£25.60 m£23.90 m
Profit / Loss£8.40 m£56.40 m£69.10 m£51.90 m
Other Equity£502.60 m£384.80 m£351.70 m£307.10 m
Preference & Minorities0000
Total Capital Employed£502.60 m£384.80 m£351.70 m£307.10 m
Debt Ratio£0.19000
Assets / Equity1.61441.61441.61441.6144
Cash / Equity0.37270.37270.37270.3727
Cash Flow2020201920182017
Cash from operating activities£63.00 m£70.20 m£63.30 m£66.40 m
Cashflow before financing£247.60 m£45.50 m£42.70 m£48.60 m
Increase in Cash£99.50 m-£4.40 m£5.00 m£15.70 m
Turnover£260.00 m£259.90 m£233.20 m£217.10 m
Cost of sales£79.80 m£76.70 m£70.20 m£65.00 m
Gross Profit£180.20 m£183.20 m£163.00 m£152.10 m
Operating Profit£10.50 m£56.10 m£68.80 m£55.10 m
Pre-Tax profit£8.40 m£56.40 m£69.10 m£51.90 m

Abcam PLC Company Background

ActivitiesAbcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.
Latest Interim Date9 Mar 2020
Latest Fiscal Year End Date14 Sep 2020

Abcam PLC Directors

2009-11-03Mr Timothy George Dye
2020-10-05Dr. Jonathan Simon MilnerDeputy Chairman
2016-09-26Mr. Jeffrey Michel IliffeExecutive Director,Chief Financial Officer
2011-08-09Mr. Mark John Alexander WebsterExecutive Director,Commercial Director
2020-09-18Lady Louise Alexandra Virginia Charlotte Patten of WincantonDirector
2014-11-03Mr. Michael Redmond
2020-09-18Mr. Giles Francis Bertram KerrDirector
2014-11-03Mr Peter Stephen Keen
2012-10-22Professor Tony Kouzarides
2017-09-22Dr. David James WarwickExecutive Director,Chief Operating Officer
2020-09-18Mr. Peter Vance AllenChairman
2016-10-31Dr. Anthony Francis MartinDirector
2018-09-24Mr. Murray Edwin HennessyChairman
2009-09-16Dr. David Douglas Cleevely PhD,FIET,FREngChairman
2011-08-09Dr. Edward William Eddie Powell PhD,FCAExecutive Director,Finance Director
2016-10-31Mr. Michael Alexander Nunes RossDirector
2019-11-13Susan Elizabeth HarrisDirector
2020-02-03 Gavin Hilary James Wood Chief Financial Officer
2020-11-04Mr. Alan Thomas HirzelChief Executive Officer
2020-09-18Ms. Mara Glickman AspinallDirector
2019-10-03Suzanne SmithLegal Officer and Company Secretary

Abcam PLC Contact Details

Company NameAbcam PLC
AddressMilton Road, 330 Cambridge Science Park, Cambridge, CB4 0FL
Telephone+44 01223 696000

Abcam PLC Advisors

RegistrarEquiniti Ltd.
Phone+44 1214157082
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
Nominated AdviserJ.P. Morgan Cazenove
Phone+44 2077424000
StockbrokerJ.P. Morgan Cazenove Ltd
Phone+44 2077424000
Remuneration ConsultantDeloitte & Touche LLP
Phone+44 2079363000
Fax+44 2075831198
AuditorPricewaterhouseCoopers LLP
Phone+44 1223460055
Fax+44 1223552336
BankNational Westminster Bank PLC
SolicitorEversheds Sutherland
Phone+44 2079194500
Fax+44 2079194919